Saxenda (liraglutide)
Direct answer
What you need to know
Evidence strength: StrongSaxenda is liraglutide, a GLP-1 receptor agonist approved for chronic weight management and given as a daily injection. The weight-management form of liraglutide, injected once daily at a 3 mg dose. It is the only one of the older agonists approved for the reason most readers of this site are here.
Key takeaways
- Molecule: liraglutide. Approved for: chronic weight management.
- Form: daily injection. Prescription-only, like every product in this class.
- Same molecule as Victoza, approved for a different use.
Important limitation: This page does not reproduce Saxenda’s label. Side-effect rates, contraindications, dosing schedules and interactions belong to the prescribing information, and we link to the class-wide guides rather than paraphrasing a label.
Next action: The label for Saxenda is published on DailyMed and is the authority on how it is taken. Separately, here is how Saxenda is priced on each route.
Primary sources: DailyMed, U.S. National Library of Medicine, U.S. Food & Drug Administration
General education, not medical advice. This page does not publish dosing instructions.
At a glance
- Molecule
- liraglutide
- Approved for
- chronic weight management
- Form
- daily injection
- Self-pay, direct from manufacturer
- Not published
- Prescription required
- Yes — as for every GLP-1 receptor agonist
The same molecule as Victoza at a higher dose, approved for weight rather than diabetes — the Ozempic and Wegovy pattern, one drug generation earlier.
The confusion worth clearing up
Being older and daily, it is often assumed to be a weaker version of Wegovy. It is a different molecule from semaglutide, not a lower dose of it.
The class, the molecule and the brand name are three different levels, and most “versus” questions in this category dissolve once they are separated — which level of that Saxenda belongs to, and what it is being compared against is the thing worth settling first.
What this page deliberately leaves out
Side-effect rates, contraindications, dosing schedules, and drug interactions for Saxenda are on its FDA-approved label, published on DailyMed. We are not going to reproduce them here from anywhere else, because a drug page that looks complete but was assembled second-hand is more dangerous than one that is visibly partial.
What we do cover, at the level of the class rather than the product:
- Side effects — what is common, what is serious, and the boxed warning.
- Dosing and titration — why doses start low and climb, and what happens at each step.
- How these medications work — the four mechanisms, and why they also explain the side effects.
Questions people ask about Saxenda
Is Saxenda a GLP-1?
Yes. Saxenda is liraglutide, a GLP-1 receptor agonist, approved for chronic weight management and given as a daily injection. "GLP-1" is the drug class; liraglutide is the molecule; Saxenda is the brand name that molecule is sold under for this use.
Is Saxenda the same as Victoza?
They are the same molecule — liraglutide — approved for different uses. Saxenda is approved for chronic weight management; Victoza for type 2 diabetes. That difference is not pharmacological, but it decides how an insurer treats each one, which is usually the practical question hiding inside "which is better".
Do you need a prescription for Saxenda?
Yes, in the United States, as for every GLP-1 receptor agonist. Anything sold as Saxenda without a prescription is not Saxenda, whatever the label says — and a product bought outside the prescribing chain carries none of the manufacturing verification the approved product does.
How much does Saxenda cost?
The manufacturer does not publish a self-pay price for Saxenda. Where a price is not published we say so rather than estimate one, so the total for this product depends on the route you take to it.
Before you act on anything here
- Saxenda is prescription-only. Anything sold as Saxenda without a prescription is not Saxenda.
- Take dosing and administration from the label on your own prescription, not from this page or any other.
- Approval status and price are checked on the dates shown and both change — re-verify before relying on either.
Sources
Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.
- FDA-approved prescribing information (drug labels)DailyMed, U.S. National Library of MedicineSupports: The approved indication and dosage form for Saxenda, and the labelled information this page deliberately does not reproduce.
- Drug approvals, labeling and safety communicationsU.S. Food & Drug AdministrationSupports: Approval status for Saxenda, checkable in Drugs@FDA and the Orange Book.
This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.